Hellström, V., Enström, Y., Zur-Mühlen, B. v., Hagberg, H., Laurell, A., Nyberg, F., . . . Lorant, T. (2016). Malignancies in transplanted patients: Multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation - experiences from a prospective, clinical, observational study. Acta oncologica, 55(6), . https://doi.org/10.3109/0284186X.2015.1130855
Chicago-Zitierstil (17. Ausg.)Hellström, Vivan, et al. "Malignancies in Transplanted Patients: Multidisciplinary Evaluation and Switch to MTOR Inhibitors After Kidney Transplantation - Experiences from a Prospective, Clinical, Observational Study." Acta Oncologica 55, no. 6 (2016). https://doi.org/10.3109/0284186X.2015.1130855.
MLA-Zitierstil (9. Ausg.)Hellström, Vivan, et al. "Malignancies in Transplanted Patients: Multidisciplinary Evaluation and Switch to MTOR Inhibitors After Kidney Transplantation - Experiences from a Prospective, Clinical, Observational Study." Acta Oncologica, vol. 55, no. 6, 2016, https://doi.org/10.3109/0284186X.2015.1130855.